#1292ef

Hikma Pharmaceuticals

#f9f9f9

Rebecca Bowman

Zeina Al Khaznachi

Majda Labadi

John Pillsbury

Laith Najjar

Bashar Shomali

Taha Abushanab

Sami Baramki

Sigurdur Olafsson

Bryan Holmes

Rachel Borland

Dan Jordan

Jim Hernon

Rachel Elliott

We are a multinational pharmaceutical group dedicated to improving the health and wellbeing of people in the markets we serve through the development, manufacture and marketing of a broad range of ... 

Our venture capital arm, Hikma Ventures
Strategically investing in businesses where our expertise and resources can accelerate growth and enhance value creation.
Visit our website for further information
To broaden our offerings and tap into opportunities in the growing digital health space, we set up Hikma Ventures in 2015. Our venture capital arm will invest in businesses where our expertise and multinational resources can accelerate revenue growth and enhance value creation. This will include start-ups at all stages of development.
We are examining opportunities globally, and seek to partner with the management teams of portfolio companies to help realise the potential of their products and technologies. Our initial investment size is up to $5 million per round. Already, we have invested in digital health businesses around the world with the potential to enhance our value chain and product pipeline